Skip to main content
Top

Reviews in Endocrine and Metabolic Disorders

2000 - 2025
Volumes
107
Issues
Chevron right icon
Issue 3/2025
GHRH - The first 50 years
Latest issue

About this journal

Reviews in Endocrine and Metabolic Disorders is an international journal dedicated to students, clinicians and researchers involved in the broad area of endocrinology and metabolism. This field of medicine and biology is rapidly advancing and a major challenge is to keep abreast of the advances in the field.

The mission of this review journal is to keep those interested individuals informed of all the latest exciting advancements that are essential to their research or clinical practice.

The format of this review journal differs from existing journals. Each of the quarterly issues covers a specific topic. Ten to twelve articles will be published by world leaders in this area. The individual papers are brief overviews of the latest developments, with insight into the basic aspects of the disease and translation into clinical aspects. Thus the student, academic clinician and practicing clinician will be able to understand the disease process and apply this knowledge to his or her area of interest. Selected readings and other essential references will enable the reader to investigate a particular topic in a more in-depth approach.

Reviews in Endocrine and Metabolic Disorders considers both unsolicited and invited review articles for publication in the journal.

Metadata
Title
Reviews in Endocrine and Metabolic Disorders
Coverage
Volume 1/2000 - Volume 26/2025
Publisher
Springer US
Electronic ISSN
1573-2606
Print ISSN
1389-9155
Journal ID
11154
DOI
https://doi.org/10.1007/11154.1573-2606

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more

ADA 2025

Unlock your free and exclusive access to the latest news from the American Diabetes Association’s 85th Scientific Sessions.

Read more